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Reported breast cancer incidence is rising in South Africa, where some women are diag-
nosed late and have poor outcomes. We studied patient and provider factors associated
with clinical stage at diagnosis among women diagnosed at the Chris Hani Baragwanath
Academic Hospital in Soweto, Johannesburg in 2015–2016.
Methods
From face-to-face interviewer-administered questionnaires we compared self-reported
socioeconomics, demographics, comorbidities, risk factors, personal and health system
barriers, and from patient clinical records, clinical staging, receptor subtype, and tumor
grade among 499 consecutive women newly diagnosed with advanced stage (III/IV) breast
cancer versus those diagnosed early (stage 0/I/II). Logistic regression models were used to
identify factors associated with advanced stage at diagnosis.
Results
Among the women, 243 (49%) were diagnosed at early and 256 (51%) at advanced stages.
In the multiple logistic regression adjusted model, completion of high school or beyond
(odds ratio (OR) 0.59, and greater breast cancer knowledge and awareness (OR 0.86) were
associated with lower stage of breast cancer at presentation. Advanced stage was associ-
ated with Luminal B (OR 2.25) and triple-negative subtypes (OR 3.17) compared to luminal
A, with delays >3 months from first breast symptoms to accessing the health system (OR
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Conclusions
Limited patient education, breast cancer knowledge and awareness, and health system inef-
ficiencies were associated with advanced stage at diagnosis. Sustained community and
healthcare worker education may down-stage disease and improve cancer outcomes.
Introduction
Breast cancer is the most common cancer among women and a major cause of cancer deaths
in women worldwide [1, 2]. Although breast cancer was once considered a disease of affluence,
its reported incidence is rising rapidly in low- and middle-income countries (LMICs), such as
South Africa (SA). In recent years, with the expanded ARV rollout, SA’s HIV control and life
expectancy have dramatically improved, whilst its non-communicable disease burden is grow-
ing[1, 3, 4]. An upper middle-income country (UMIC), with an annual per capita Purchasing
Power Parity (PPP) gross domestic product of approximately US$13,500[5, 6], SA has a better
developed healthcare system than most sub-Saharan African countries. Its private sector facili-
ties are comparable to those of high income countries (HICs), and its public sector facilities,
serving approximately 85% of the population, include a number of relatively well equipped
and staffed academic hospitals.
The published age-standardized annual breast cancer incidence rate (ASR) per 100,000 is
29.1 among black SA women, much lower than the rates among mixed race, Asian and white
SA women (52.92–79.3), and amongst USA black (125.1) and white women (127.7) [1, 7–10].
Yet SA breast cancer mortality rates among socioeconomically disadvantaged patients,
although poorly reported, are assumed to be high [11, 12]. This is partly due to more than 70%
of patients being diagnosed with advanced stage disease in rural and urban health care settings
[3, 13–16]. In the USA, black women also have higher breast cancer-specific mortality rates
than do white women [17]. Younger age at presentation and greater proportions of more
aggressive breast cancer subtypes are also thought to contribute to those higher mortality rates.
[8, 9, 14, 17–21]. Yet Johannesburg and South African National Cancer Registry (SANCR)
data reveal that, like USA women, more than 60% of SA women, regardless of race, are diag-
nosed with estrogen receptor-positive (ER+) tumors [14, 21]. Hence outcomes should improve
among SA women if they do not encounter delays in their diagnosis and treatment.
Despite the large proportion of women who present with late stage disease in SA, we
observed an encouraging down-staging of invasive breast cancer diagnosed at the Chris Hani
Baragwanath Academic Hospital (CHBAH) in Soweto, Johannesburg, between 2007 and 2012.
The proportion of stage I and II cancers increased over that time interval from approximately
30% to more than 50% [22]. We attributed this improvement to the implementation of an
open access clinic and successful breast cancer awareness campaigns. But we still fall well short
of the 80–90% proportion of early-stage disease reported for HICs[2]. The personal, societal
and health system barriers that impact stage at diagnosis are not well understood in our set-
ting. It is hoped that modifiable factors identified may be addressed in future intervention
studies applicable to urban patients treated at CHBAH and to disadvantaged patients from
other regions of the country. Prior studies from LMICs and HICs suggest that various patient
and health system factors may affect the timeliness of breast cancer diagnosis [4, 23–32]. To
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inform future interventional work, we undertook a study of socio-demographic, clinical, life-




CHBAH is a public academic hospital located in Soweto, in the southwestern part of Johannes-
burg, South Africa. It serves as the referral facility for approximately 3 million people who live
within a 60 km radius of the hospital, as well as for patients from farther afield.
In SA’s hierarchical referral system, doctors and nurses at primary care clinics refer patients
with breast conditions either directly to an academic tertiary hospital or to a local secondary
hospital, which can provide general hospital care and some diagnostic services and can refer
patients who need more advanced care to a tertiary hospital. CHBAH has a specialized Surgical
Breast Unit where currently 25–35 patients per month are diagnosed with breast cancer.
Recruitment and data collection
In this cross-sectional survey, from January 8, 2015, through December 31, 2016, at the
CHBAH, 499 consecutive female patients who were 18+ years and newly diagnosed with stage
0-IV breast carcinoma completed an informed, written consent and were enrolled into our
study. We had no refusals to participate; therefore our study represents all women who pre-
sented at the clinic during this time period. Self-reported socioeconomic and demographic
variables were collected, namely date of birth from which age at diagnosis was determined,
marital status, highest education level completed, household possession score (determined
from home ownership, car ownership, microwave, washing machine, indoor running water,
flush toilet inside home with calculations described in the legend to Table 1), employment sta-
tus and parity (full-term pregnancies). Lifestyle risk factors (BMI, calculated from weight and
height measurements, self-reported alcohol consumption, smoking, hypertension, diabetes,
and cardiovascular disease) and clinical data (HIV status measured by the ELISA test, intrinsic
breast cancer subtypes, grade, and clinical staging) were recorded. Intrinsic breast cancer sub-
typing included Allred scoring for definition of estrogen and progesterone receptor (ER and
PR) status [33]. Luminal A subtypes were defined as ER / PR+ HER2-negative and Ki67
15%; Luminal B as ER/ PR+ HER2-positive and/or Ki67>15%; HER2-enriched as ER/PR-
and HER2- positive; and triple negative as ER/PR- and HER2-negative.
The University of the Witwatersrand Human Research Ethics Committee (HREC) Medical
approved the study (M141102, dated January 7, 2015. Clinical data were extracted from the
electronic clinical records in the CHBAH Breast Unit and linked to the Barriers to Care ques-
tionnaire described below. The anonymized data set used for the analysis is provided as sup-
porting information, S1 Table).
Barriers to care questionnaire
The Barriers to Care questionnaire was developed from a literature review on barriers to early-
stage presentation of breast cancer among women from LMICs (which referenced validated
survey instruments for HICs), considering specific parameters unique to CHBAH. Key themes
emerged around awareness of breast cancer and its risk factors[34–39], attitudes toward breast
cancer and health-seeking behavior[40–46] and personal and health system barriers to access-
ing care[47–60]. Two focus group sessions, each comprising 15 former breast cancer patients
were undertaken. They reiterated the emergent themes from the literature and supported their
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Table 1. Comparison of the socio-demographic, clinical and lifestyle characteristics, knowledge and awareness of breast cancer and health system barriers among
patients diagnosed with early and late stage disease at the CHBAH breast clinic.
Total Early stage Late stage ρ- Chi square
(0-II) (III & IV) value Statistic/DF
N = 499(%) N = 243 (%) N = 256 (%)
SOCIO-DEMOGRAPHIC CHARACTERISTICS
Age
<40 69 (13.8) 23 (9.4) 46 (18.0) 0.013 12.6788
40–49 124 (24.8) 58 (23.9) 66 (25.8) DF = 4
50–59 120 (24.1) 59 (24.3) 61 (23.8)
60–69 102 (20.4) 62 (25.5) 40 (15.6)
70 and above 84 (16.8) 41(16.9) 43 (16.8)
Marital status
Single 119 (24.0) 55 (22.7) 64 (25.2) 0.736 0.6133
Married/co-habiting 216 (43.6) 105 (43.4) 111 (43.7) DF = 2
Divorced/widowed 161 (32.4) 82 (33.9) 79 (31.1)
Level of education
Completion of Informal / Primary 142 (28.5) 56 (23.1) 86 (33.6) 0.010 6.6688
Completion of High school/ any tertiary education 348 (71.5) 186 (76.9) 170 (66.4) DF = 1
Household socioeconomic status a




Unemployed 229 (45.9) 118 (48.5) 111 (43.4) 0.244 2.8184
Employed 136 (27.2) 58 (23.9) 78 (30.5) DF = 2
Retired 134 (26.9) 67 (27.6) 67 (26.1)
Parityb (Mean ± S.D.) 3.00 ± 1.84 2.84 ± 1.68 3.15 ± 1.97 0.064 t = -1.8596
DF = 469
CLINICAL & LIFESTYLE FACTORS
BMIb (Mean ±S.D.) 31.42 ± 7.85 31.77 ± 6.98 31.08 ± 8.63 0.337 0.9645
DF = 468
Alcohol consumption
Yes 100 (20.0) 50 (20.6) 50 (19.5) 0.771 0.0849
No 399 (80.0) 193 (79.4) 206 (80.5) DF = 1
Smoking
Yes 35 (7.0) 21 (8.6) 14 (5.5) 0.165 1.9247
No 464 (93.0) 222 (91.4) 242 (94.5) DF = 1
Hypertension
Yes 200 (40.3) 113 (46.7) 87 (34.3) 0.005 7.9727
No 296 (59.7) 129 (53.3) 167 (65.7) DF = 1
HIV Status
Positive 113 (22.7) 44 (18.9) 69 (28.6) 0.013 6.1983
Negative 361 (72.3) 189 (81.1) 172 (71.4) DF = 1
Unknown 25 10 15
Receptor subtype–intrinsic
Luminal A 54 (10.9) 31 (12.9) 23 (9.0) 0.276 3.8707
Luminal B 350 (70.6) 171 (71.0) 179 (70.2) DF = 3
HER2 enriched 33 (6.6) 16 (6.6) 17 (6.7)
(Continued)
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relevance to our Soweto urban setting. Ten research and nursing staff then developed the 24
item questionnaire that covered 8 major domains, namely awareness and knowledge of breast
cancer (9 questions); personal hurdles/barriers to seeking help (2 questions); family hurdles
(3 questions); community hurdles (1 question); cultural hurdles (2 questions); economic hur-
dles (4 questions); and health system barriers to care (3 questions).Yes, no and unsure were
response options to questions asked and a five point agreement Likert Scale (strongly disagree,
disagree, unsure/neutral, agree, strongly agree) was used to measure respondents’ agreement
with statements used in the questionnaire (provided as supplementary information, S1 Text).
The knowledge and awareness score (0–9) was calculated from summations of 1 and 0 values
assigned respectively for yes and no answers to questions and for correct and incorrect agree-
ments to statements (irrespective of strength of agreement). The participant pathways in the
referral health system were probed in detail covering choice of initial consultation, referral
within the primary and secondary healthcare facilities, and the number of visits experienced
prior to reaching the CHBAH Breast Clinic. We queried time intervals between symptom
awareness and visits to healthcare facilities for diagnosis and treatment and between all visits
prior to reaching CHBAH, and asked about personal reasons for delays longer than 1 month.
We also probed causes for delays within the referral network. We evaluated the understanding
of each question by the research team and former patients and made adjustments for local con-
text and language usage. Finally the reliability of the questionnaire was verified using the test
re-test methodology on 36 consenting participants. The questionnaire was repeated and
answers compared within 2–4 weeks following the baseline visit. In each case the interview
was conducted by the same interviewer who administered the first questionnaire. Scores from
the first interview were compared to those from the second interview using Cohen’s kappa
coefficient (k). The coefficient ranged from 0.7030 to 1.000 indicating substantial to perfect
Table 1. (Continued)
Total Early stage Late stage ρ- Chi square
(0-II) (III & IV) value Statistic/DF
N = 499(%) N = 243 (%) N = 256 (%)
TRIPLE NEGATIVE 59 (11.9) 23 (9.5) 36 (14.1)
Grade
Low/intermediate 275 (59.0) 133 (60.2) 142 (58.0) 0.626 0.2371
High 191 (41.1) 88 (39.8) 103 (42.0) DF = 1
Unknown 33 22 11
KNOWLEDGE (score 0–9)c
Mean ± S.D 5.86 ± 1.88 6.20 ± 1.73 5.53 ± 1.97 0.0001 DF = 497
HEALTH SYSTEM FACTORS
Prior clinical breast examination
None/Self 481 (96.4) 233 (95.9) 248 (96.9) 0.553 0.3516
Clinician 18 (3.6) 10 (4.1) 8 (3.1) DF = 1
Clinical waiting times as a barrier
Yes 42 (8.4) 23 (9.5) 19 (7.4) 0.411 0.675
No 457 ((1.6) 220 (90.5) 237 (92.6) DF = 1
aHOUSEHOLD SOCIO-ECONOMIC STATUS (possessions) score determined from: (Home ownership = 1, Car ownership = 1, Microwave = 1, Washing
machine = 1, Indoor running water = 1, Flush toilet inside home = 1. Denominator = 6 (1 for Yes, 0 for No)
bAnalyzed as continuous variables DF = Degrees of freedom.
cSELF-REPORTED KNOWLEDGE/ AWARENESS OF BREAST CANCER: 1 was allocated for every correct answer, 0 for wrong answer or don’t know for each of 9
questions probing knowledge of breast cancer and symptoms.
https://doi.org/10.1371/journal.pone.0192071.t001
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agreement except for one question with a k of 0.5567 which indicates moderate agreement.
(The questionnaire is provided as supplementary information, S1 Text). The survey was com-
pleted via one-on-one, face-to-face interviews between participants and a trained, multi-lin-
gual study interviewer in a private room. Interviews were conducted in English and in the
mother tongue of participants as required. Patients were grouped by stage at diagnosis as early
(0-II) or advanced (III-IV). We compared the patient groups with respect to demographic,
socioeconomic and clinical characteristics and responses to the Barriers to Care questionnaire.
From the ‘barrier to care’ questionnaire data, we categorized women by time between aware-
ness of a breast symptom and first visit to a health care facility and by the types of health care
facilities they visited prior to CHBAH: self-referral directly to CHBAH or after a primary care
clinic visit or referral from a primary care clinic to a secondary care hospital before CHBAH.
We also grouped patients by the number of visits to each type of facility.
Statistical analysis
We used the Pearson chi squared and Fisher’s exact tests to examine differences in the propor-
tion of early/advanced stage between categorical variables. We computed means and medians
for continuous variables and used Student’s t-test and the Wilcoxon rank-sum test to deter-
mine differences between groups in means and medians, respectively. To examine associations
with advanced stage, we then developed multivariable logistic regression models of factors. We
included in the multivariate models variables for which p-values were <0.1 in bivariate analy-
sis. ORs were examined in 4 models by adding in a stepwise fashion, factors of influence (for
socio-demographic, clinical and lifestyle, knowledge and awareness, and health system) to
examine the association between these factors and advanced presentation of breast cancer.
Analysis was performed using Stata version 14 (StataCorp Ltd, Texas, USA).
Results
Of the 499 enrolled women, 243 (48.7%) were diagnosed with early-stage disease (0-II), includ-
ing 11 (4.5%) with in-situ cancers and 256 (51.3%) with advanced-stage disease (III-IV). Char-
acteristics of the cohort are summarized in Table 1.
Although age overall was not associated with advanced stage at diagnosis, women <40
years had a higher risk of diagnosis at an advanced stage than women >40 years (p = 0.013).
Other factors that initially appeared to be associated with advanced-stage disease were no high
school education, lower household socio-economic status, higher parity, lower score on self-
reported knowledge and awareness of breast cancer, no hypertension, and HIV co-infection.
Table 2 describes the association of personal delays and health system factors with
advanced-stage diagnosis.
Women who reported a delay of>1 month between identifying breast symptoms and their
first visit to the health system were more likely than those who made the first visit sooner to be
diagnosed at a late stage (p< 0.001). As shown in Table 3, the two most commonly stated rea-
sons for delays were fear of diagnosis or treatment and failure to recognize that breast symp-
toms were serious. Other reasons were conflicting commitments, such as caring for sick family
members and transport problems.
Most participants (64.7%) referred themselves to CHBAH or were referred directly by a pri-
mary care clinic or a private general practitioner, bypassing the secondary hospitals. Among
those patients, more than half had only one visit prior to diagnosis, and those with more visits
before reaching CHBAH were more likely to be diagnosed at a late stage (ρ<0.001). Among
patients seen at secondary hospitals, more than 80% had at least 3 visits prior to diagnosis and
the actual number of visits had no further impact on stage at presentation. Repeat visits within
Barriers to breast cancer care South Africa
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the referral system appear to have been caused by failure to diagnose and delays with appoint-
ments and test results. The details are provided as supporting information S2 Table.
In the bivariate analysis Table 4, those who completed high school/ any tertiary education
were at lower risk for advanced -stage presentation (OR = 0.60, 95%CI: 0.40–0.88) than those
who had informal or only primary school education. For every unit increase in parity there
was a borderline higher risk of advanced stage presentation, (OR 1.10, 95%CI: 0.99–1.21).
Those treated for hypertension were found to be at lower risk for advanced stage at diagnosis
(OR = 0.59, 95%CI: 0.41–0.85) as were those with greater knowledge and awareness of breast
Table 2. Descriptive statistics for patients presenting with early compared with late stage breast cancer at CHBAH breast clinic that experienced personal and/or
health system delays.
Total Early stage Late stage ρ- Chi-square
(0–11) (III & IV) value Statistic/DF
N = 499 (%) N = 243 (%) N = 256 (%)
Time to first presentation to HS
<1 month 307 (61.5) 173 (71.2) 134 (52.3) <0.001 22.881
1–3 months 64 (12.8) 30 (12.3) 34 (13.3) DF = 2
>3 months 128 (25.7) 40 (16.5) 88 (34.4)
Residential distance from CHBAH
< 10km 206 (41.3) 105 (43.2) 101 (39.5) 0.328 2.2277
10- 20km 104 (20.8) 54 (22.2) 50 (19.5) DF = 2
>20km 189 (37.9) 84 (34.6) 105 (41.0)
Number of HS visits before reaching CHBAH
0–1 257 (51.5) 145 (59.7) 112 (43.8) 0.002 12.661
2 73 (14.6) 30 (12.3) 43 (16.8) DF = 2
3 169 (33.9) 68 (28.0) 101 (39.4)
Referral mode to CHBAH
Self + primary–direct 323 (64.7) 166 (68.3) 157 (61.3) 0.103 2.639
Primary/secondary–indirect 176 (35.3) 77 (31.7) 99 (38.7) DF = 1
Self/primary (direct) 323 (64.7) 166 (68.3) 157 (61.3) <0.001 15.439
0–1 visits–self-primary 251 (77.7) 143(86.1) 108 (68.8) DF = 2
2 visits self/primary 49 (15.2) 18 (10.9) 31 (19.7)
3 visits self/primary 23 (7.1) 5 (3.0) 18 (11.5)
Primary/secondary (indirect) 176 (35.3) 77 (31.7) 99 (38.7) 0.716 0.6618
0-1visits primary/secondary 6 (3.4) 2 (2.6) 4 (4.1) DF = 2
2 visitsprimary/secondary 24 (13.6) 12 (15.6) 12 (12.1)
3 visitsprimary/secondary 146 (83.0) 63 (81.8) 83 (83.8)
https://doi.org/10.1371/journal.pone.0192071.t002
Table 3. Reasons for personal delays into the health system.
Staging at diagnosis
Reasons for delay Early stage Late stage Total
N = 243 % N = 256 % N = 499 %
No delay 173 71.19 136 53.13 309 61.92
Fear of diagnosis 13 5.35 20 7.81 33 6.61
Thought it was minor ailment 56 23.05 96 37.50 152 30.46
No one to look after the children 0 0.00 3 1.17 3 0.60
Worried no money for treatment 1 0.41 1 0.39 2 0.40
Total 243 100.00 256 100.00 499 100.00
https://doi.org/10.1371/journal.pone.0192071.t003
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Table 4. Bivariate analysis of variables associated with late stage presentation amongst patients diagnosed with breast cancer at the CHBAH Breast Clinic from
2014–2016.
Variables Bivariate analysis
OR (95% CI) P-value
SOCIO-DEMOGRAPHIC CHARACTERISTICS
Age




70 and above 1.01 (0.58–1.77)
Marital status




Completion of Informal / Primary Reference 0.0096
Completion of High school/ any tertiary education 0.60 (0.40–0.88)





Parity 1.10 (0.99–1.21) 0.0624
CLINICAL AND LIFESTYLE FACTORS
BMI 0.99 (0.97–1.01) 0.3353
Smoking
No Reference
Yes 0.61 (0.30–1.23) 0.164
Alcohol consumption
No Reference
Yes 0.94 (0.60–1.45) 0.7707
Hypertension
No Reference
Yes 0.59 (0.41–0.85) 0.0047
HIV Status
Negative Reference
Positive 1.72 (1.12–2.65) 0.1125
Intrinsic receptor subtype–IHC
Luminal A Reference
Luminal B 1.86 (1.10–3.14) 0.0450
HER2 enriched 1.77 (0.77–4.07)
Triple negative 2.61 (1.69–5.30)
KNOWLEDE/AWARENESS SCORE (0–9) 0.82 (0.74–0.91) 0.0001
HEALTH SYSTEM FACTORS
Prior clinical breast examination
Clinician Reference
None/self 1.33 (0.52–3.43) 0.5531
Clinic waiting times barrier to attendance
(Continued)
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cancer (OR = 0.82, 95%CI: 0.74–0.91). Patients aged<40 years (OR = 1.93, 95%CI: 1.05–3.58)
and those with luminal B and triple negative breast cancer subtypes (OR = 1.86, 95%CI: 1.10–
3.14 and OR = 2.61, 95%CI: 1.69–5.30 respectively) were at higher risk for advanced stage at
diagnosis than those with a luminal A subtype. Those who reported having taken >3 months
after noting a breast symptom to visit a healthcare facility (OR = 2.84, 95%CI: 1.84–4.39) were
also at higher risk for advanced-stage disease at diagnosis than patients who had taken less
than one month. Those who had more than one visit prior to reaching CHBAH also were
more likely to be diagnosed at an advanced stage than patients who had no more than one visit
(mainly those who had self and direct clinic referral to CHBAH).
Associations significant at the bivariate level were further explored in Table 5 in individual
and combined multiple logistic regression models 1–4 and 5–7 respectively.
Socio-demographic factors (model 1) independently explained 4% of the variance and were
shown to influence the likelihood of advanced stage at diagnosis in part by younger age and
decreased level of education. Clinical and lifestyle factors (model 2) explained 3% of the vari-
ance, with Luminal B and Triple Negative having greater odds of advanced-stage presentation
than Luminal A subtype. Greater knowledge and awareness of breast cancer had a lower odds
for advanced-presentation (OR 0.82, 95%CI 0.74–0.91) and explained just over 2% of the vari-
ance (model 3). Health system factors (model 4) explained 6% of the variance with patient
delays>3 months having more than 3 times greater odds for advanced stage–presentation. In
addition patients experiencing >2 referral health system visits had greater than twice the odds
for advanced-stage presentation compared with those having 0 visits (self-referrals) and 1 visit
(within the primary health system). In the final model with all factors included (model 7), 13%
of the variance was explained. Notably, the associations of advanced stage with lower educa-
tion, tumour subtype, and health system factors were not attenuated upon adjustment; the
association with a lower knowledge score was slightly attenuated, whereas associations with
Table 4. (Continued)
Variables Bivariate analysis
OR (95% CI) P-value
No Reference
Yes 0.77 (0.41–1.45) 0.411
Time to first presentation to health system
<1 month Reference <0.001
1–3 months 1.46 (0.85–2.51)
>3 months 2.84 (1.84–4.39)
Residential distance from CHBAH
< 10km Reference 0.3278
10- 20km 0.96 (0.6–1.5)
>20km 1.3 (0.9–1.9)




Referral mode to CHBAH
Self + primary–direct route Reference 0.1023
Primary/secondary–indirect route 1.36 (0.94–1.97)
Variables at p<0.1 on bivariate analysis are presented in boldface and were considered in the multiple logistic regression model analysis.
IHC: Immunohistochemistry.
https://doi.org/10.1371/journal.pone.0192071.t004
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Table 5. Multiple logistic regression models of factors influencing late stage disease presentation among patients diagnosed with breast cancer at CHBAH Breast
Clinic 2014–2016.
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household socioeconomic status, parity, HIV, and treated hypertension were no longer signifi-
cant in mutually adjusted models. Thus, although HIV+ women tended to present at more
advanced stages, because they were younger there was some attenuation of this association
upon adjustment for either of these factors.
A cluster analysis was undertaken to distinguish group associations of sociodemographic
variables with time to breast cancer disease presentation. The analysis was performed on con-
tinuous variables, omitting correlating variables, namely age, self-reported parity, self-reported
household SES score (0–6) (based on home ownership, car ownership, hot and cold running
water in home, flush toilet in house, owning a microwave, owning a washing machine) and the
self-reported knowledge score (0–9). Three clusters were generated using the K mean and an
ANOVA was performed to identify any statistical differences in the means between the 3 clus-
ters and stage at diagnosis. The results are tabulated in the supporting information S3 Table
and reveal no statistical differences between the three groups.
Discussion
In our cohort of predominantly black women from socioeconomically disadvantaged urban
communities around Johannesburg, patients with less than a high school education, those with
little awareness or knowledge of breast cancer, those with luminal B and triple negative breast
cancer subtypes, those who took more than three months from first recognition of their breast
symptoms to visit a health care facility, and those who experienced more than 2 visits within
the primary and secondary health system referral network were more likely to have been diag-
nosed at an advanced stage. We attribute the delay in making the first visit mainly to the two
extremes of either patient lack of awareness of symptoms or fear of diagnosis. However, the
multiple visits due to healthcare system failure to diagnose or inefficiency in scheduling
appointments and retrieving laboratory results were major contributors to diagnostic delays
and markedly impacted patient outcomes, especially those with aggressive receptor subtypes.
More than 90% of the cohort reported receiving no routine clinical breast examinations during
routine visits to women’s health and other clinics prior to experiencing their breast symptoms.
Thus clinical breast examination services provided by trained doctors and nurses, though
affordable, are not a standard feature of the primary health care system in SA.
Table 5. (Continued)
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Pseudo R2 0.0426 0.0332 0.0234 0.0608 0.0646 0.0803 0.1279
https://doi.org/10.1371/journal.pone.0192071.t005
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Additionally, we found that HIV+ women tended to have more advanced stage. This was in
part due to their younger age, but HIV+ women can be reached through their existing contacts
with the health system. Education on breast awareness could be included when raising aware-
ness of women’s cancer issues in HIV+ women. Although breast cancer is not a HIV-associ-
ated malignancy, as it is a common cancer in women in general, it remains a relevant issue in
HIV-affected women too.
According to other studies, lack of knowledge and awareness of breast cancer and symp-
toms and fear of diagnosis and treatments are widespread and associated with advanced-stage
diagnosis in other LMICs. Geographical isolation, inadequate financial resources, a preference
for consulting traditional healers linked with cultural and religious beliefs, and a shortage of
adequately trained healthcare professionals and facilities to diagnose and treat cancer are also
widespread. Most LMICs also have limited cancer prevention and control policies and cancer
registries able to monitor incidence and mortality [4, 12, 15, 23, 27, 28, 30, 31, 61].
In HICs, routine cancer screening is available, and healthcare services are well resourced.
Yet in the USA, the breast cancer mortality rate is disproportionately high among blacks due
to more advanced stage at diagnosis (after controlling for the higher proportion of triple nega-
tive subtype). Lack of knowledge of symptoms and risk factors, fear of treatments, higher
financial burden of treatments, more lifestyle-associated risk factors and comorbidities, cul-
tural issues, lack of partner support, stigma and taboo, and inferior health care services may all
be associated with delays in accessing treatment[2, 24, 30, 32]
Our findings are based on a sample of patients from an urban black community in and
around Johannesburg and may therefore have limited generalizability. Our information about
delays in care seeking and numbers and types of healthcare visits is based on patient survey
responses, rather than administrative data, which may be biased or less accurate. With a near
50% late stage disease in a sample size of 500 women, we had 80% power to detect ORs of 1.66
or larger for exposure prevalence of 50% and an OR of 2.08 or larger for rarer exposure preva-
lence of 10%. Larger studies will be required to detect smaller ORs. Findings were consistent
with other data supporting associations with stage at diagnosis.
Fortunately, many of these factors are modifiable. Partnering with Cancer NGOs in SA,
coordinating outreach programs at community and clinic levels to increase knowledge and
awareness of breast cancer symptoms and risk factors, allaying fears of diagnosis and treat-
ments, and active navigation of patients through the referral networks would undoubtedly
enable more patients to be diagnosed and treated at an early stage. In addition, ongoing educa-
tion and advisory support for primary and secondary tier doctors and nurses supported by the
implementation of efficient referral algorithms would improve breast cancer detection and
prevent unnecessary delays within the referral network.
Conclusion
Advanced-stage diagnosis of breast cancer among urban SA communities relying on public
healthcare services is associated with patient- and health system-related barriers to care. Com-
munity and healthcare worker awareness and education programs, swift diagnostic workups
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